UBS Hikes Meta Platforms' Target From $872 to $908: Is the GenAI Ad Revenue Machine Just Warming Up?

UBS raised its price target on Meta Platforms to $908 from $872 while reiterating a Buy rating, signaling improved confidence in the stock's outlook. The update is positive for sentiment but is primarily analyst commentary rather than new operating results or guidance. The move may support shares modestly, though it is unlikely to be a major market-wide catalyst.

Analysis

UBS raised its price target on Meta Platforms to $908 from $872 while reiterating a Buy rating, signaling improved confidence in the stock's outlook. The update is positive for sentiment but is primarily analyst commentary rather than new operating results or guidance. The move may support shares modestly, though it is unlikely to be a major market-wide catalyst.